Education
About Us
Working with TipRanks
Follow Us
Inogen (INGN)
NASDAQ:INGN
INGN Stock Chart & Stats
$6.21
$0.43(4.59%)
At close: 4:00 PM EST
$6.21
$0.43(4.59%)
Day’s Range― - ―
52-Week Range$5.70 - $12.91
Previous CloseN/A
Volume110.44K
Average Volume (3M)175.29K
Market Cap
$159.90M
Enterprise Value$69.55M
Total Cash (Recent Filing)$124.50M
Total Debt (Recent Filing)$18.22M
Price to Earnings (P/E)―
Beta1.31
Next Earnings
Feb 24, 2026EPS Estimate
-0.36Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.20
Shares Outstanding27,148,481
10 Day Avg. Volume170,224
30 Day Avg. Volume175,293
Financial Highlights & Ratios
PEG Ratio0.09
Price to Book (P/B)1.25
Price to Sales (P/S)0.65
P/FCF Ratio-19.40
Enterprise Value/Market Cap0.43
Enterprise Value/Revenue0.20
Enterprise Value/Gross Profit0.43
Enterprise Value/Ebitda-8.60
Forecast
1Y Price Target
$13.00Price Target Upside109.34% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Clinical ValidationPatient-use study reporting high user satisfaction with Aurora masks supports adoption and could accelerate market uptake.
Guidance And ProfitabilityAnalyst notes company reiterated guidance for positive adjusted EBITDA, indicating management confidence in improving profitability.
Product LaunchAnalyst highlights launch of the Aurora CPAP mask family as an opportunity to open a new respiratory-device revenue stream and broaden customer reach.
Bears Say
Competitive PressureAnalyst believes entering the CPAP mask market will be challenging because established competitors hold strong market positions that may limit share gains.
Margin PressureAnalyst highlights a notable year-over-year decline in gross margin, signaling potential pressure on profitability unless cost or pricing trends improve.
Revenue Timing RiskRevenue missed expectations due to several large customer orders shifting into a later reporting period, creating risk of uneven revenue recognition.
Inogen News
INGN FAQ
What was Inogen’s price range in the past 12 months?
Inogen lowest stock price was $5.70 and its highest was $12.91 in the past 12 months.
What is Inogen’s market cap?
Inogen’s market cap is $159.90M.
When is Inogen’s upcoming earnings report date?
Inogen’s upcoming earnings report date is Feb 24, 2026 which is in 26 days.
How were Inogen’s earnings last quarter?
Inogen released its earnings results on Nov 05, 2025. The company reported -$0.2 earnings per share for the quarter, beating the consensus estimate of -$0.208 by $0.008.
Is Inogen overvalued?
According to Wall Street analysts Inogen’s price is currently Undervalued.
Does Inogen pay dividends?
Inogen does not currently pay dividends.
What is Inogen’s EPS estimate?
Inogen’s EPS estimate is -0.36.
How many shares outstanding does Inogen have?
Inogen has 27,148,481 shares outstanding.
What happened to Inogen’s price movement after its last earnings report?
Inogen reported an EPS of -$0.2 in its last earnings report, beating expectations of -$0.208. Following the earnings report the stock price went down -8.313%.
Which hedge fund is a major shareholder of Inogen?
Currently, no hedge funds are holding shares in INGN
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Inogen Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$13.00 (109.34% Upside)
$13.00 (109.34% Upside)
Blogger Sentiment
Bullish
INGN Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 194.5K Shares
Last Quarter.
Last Quarter.
Technicals
SMA
Negative
20 days / 200 days
Momentum
-20.40%
12-Months-Change
Fundamentals
Return on Equity
-13.27%
Trailing 12-Months
Asset Growth
0.27%
Trailing 12-Months
Company Description
Inogen
Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One, a portable device that concentrate the air around the patient to provide a single source of supplemental oxygen; Inogen At Home stationary oxygen concentrators; Inogen Tidal Assist Ventilators, as well as related accessories. The company also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California.
INGN Company Deck
INGN Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call highlighted consistent revenue growth, strong international B2B performance, and successful product launches, demonstrating positive momentum and strategic execution. However, challenges such as decreased direct-to-consumer sales and rental revenue decline were noted, impacting overall profitability.View all INGN earnings summariesINGN Stock 12 Month Forecast
Average Price Target
$13.00
▲(109.34% Upside)
Technical Analysis
Ownership Overview
2.30% Insiders
18.15% Mutual Funds
0.16% Other Institutional Investors
70.29% Public Companies and
Individual Investors